Stay updated on Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.

Latest updates to the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a minor update to the study details page.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision label on the page was updated from v3.6.0 to v3.6.3, indicating a minor page/version update. This change is a metadata/versioning update and does not modify substantive content or study details.SummaryDifference0.0%

- Check38 days agoChange DetectedThe study locations count was updated to 85 locations, down from 86, indicating a reduction in participating sites and reflecting the current geographic footprint of the trial.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page gains new user guidance sections for reading the study record and joining, and clearly signals recruitment has ended; formatting tweaks to the Intervention/Treatment header and a new version label (v3.6.0) are also present.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page shows a new Revision: v3.5.5, replacing the prior Revision: v3.5.4, indicating a small metadata update. There is no visible change to study content or user-facing features based on this update.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.5.4 is now shown on the page, replacing the previous revision v3.5.3 and signaling a new version of the page.SummaryDifference0.0%

Stay in the know with updates to Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.